Compositions and methods for silencing apolipoprotein c-iii...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/713 (2006.01) C12N 15/113 (2010.01) A61K 9/14 (2006.01) A61K 9/48 (2006.01) A61P 3/06 (2006.01) A61P 9/10 (2006.01) C07H 21/02 (2006.01) C07K 14/775 (2006.01) C12N 15/88 (2006.01)

Patent

CA 2750561

The present invention provides compositions comprising therapeutic nucleic acids such as interfering RNA that target apolipoprotein C-III (APOC3) gene expression, lipid particles comprising one or more (e.g., a cocktail) of the therapeutic nucleic acids, methods of making the lipid particles, and methods of delivering and/or administering the lipid particles (e.g., for the treatment of lipid diseases or disorders such as atherosclerosis or a dyslipidemia such as hypertriglyceridemia or hypercholesterolemia).

La présente invention porte sur des compositions qui comportent des acides nucléiques thérapeutiques tels que de l'ARN interférant qui ciblent l'expression du gène de l'apolipoprotéine C-III (APOC3), des particules lipidiques comportant un ou plusieurs (par exemple un cocktail) des acides nucléiques thérapeutiques, des procédés de fabrication des particules lipidiques et des procédés de distribution et/ou d'administration des particules lipidiques (par exemple pour le traitement de maladies ou de troubles lipidiques tels que l'athérosclérose ou une dyslipidémie telle que l'hypertriglycéridémie ou l'hypercholestérolémie).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Compositions and methods for silencing apolipoprotein c-iii... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods for silencing apolipoprotein c-iii..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for silencing apolipoprotein c-iii... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1815857

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.